FDA Cancels Meeting with Repligen (REGN) for RG1068; Will Get CRL on June 21st
Go back to FDA Cancels Meeting with Repligen (REGN) for RG1068; Will Get CRL on June 21stRepligen Corp (NASDAQ: RGEN) | Delayed: 167.86 -3.42 (2%) | |||||
---|---|---|---|---|---|---|
Previous Close | $171.28 | 52 Week High | $33.79 | |||
Open | $169.82 | 52 Week Low | $20.07 | |||
Day High | $173.48 | P/E | 239.80 | |||
Day Low | $165.91 | EPS | $0.70 | |||
Volume | 555,959 |